Research output per year
Research output per year
Personal profile
Research interests
My research focuses on the identification of tumor specific mutant antigens recognized by the immune system as foreign that serve as the target of a T-cell response against tumors. We take advantage of cancer genomics and bioinformatics techniques to detect tumor-specific mutations that accumulate during transformation and use this information to predict which mutations are potentially antigenic.
Clinical interests
Cancer/tumor immunotherapy
Available to Mentor:
- PhD/MSTP Students
Fingerprint
Dive into the research topics where Jeffrey Ward is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer
Auberle, C., Gao, F., Sloan, M., Morgensztern, D., Winkler, L., Ward, J. P., Devarakonda, S., Rearden, T. P., Govindan, R. & Waqar, S. N., Jun 30 2024, In: Journal of Thoracic Disease. 16, 6, p. 3782-3793 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
Meng, W., Takeuchi, Y., Ward, J. P., Sultan, H., Arthur, C. D., Mardis, E. R., Artyomov, M. N., Lichti, C. F. & Schreiber, R. D., Aug 2024, In: Cancer immunology research. 12, 8, p. 988-1006 19 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Trends in Stage I Lung Cancer
Singareddy, A., Flanagan, M. E., Samson, P. P., Waqar, S. N., Devarakonda, S., Ward, J., Herzog, B. H., Rohatgi, A., Robinson, C., Gao, F., Govindan, R., Puri, V. & Morgensztern, D., Mar 2023, In: Clinical Lung Cancer. 24, 2, p. 114-119 6 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study
LUNAR Study Investigators, Leal, T., Kotecha, R., Ramlau, R., Zhang, L., Milanowski, J., Cobo, M., Roubec, J., Petruzelka, L., Havel, L., Kalmadi, S., Ward, J., Andric, Z., Berghmans, T., Gerber, D. E., Kloecker, G., Panikkar, R., Aerts, J., Delmonte, A. & Pless, M. & 6 others, , Sep 2023, In: The Lancet Oncology. 24, 9, p. 1002-1017 16 p.Research output: Contribution to journal › Article › peer-review
Open Access30 Scopus citations -
BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy
Salmon, A. J., Shavkunov, A. S., Miao, Q., Jarjour, N. N., Keshari, S., Esaulova, E., Williams, C. D., Ward, J. P., Highsmith, A. M., Pineda, J. E., Taneja, R., Chen, K., Edelson, B. T. & Gubin, M. M., May 2022, In: Cancer immunology research. 10, 5, p. 597-611 15 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations